Due to the cytotoxic effect of antimicrobial peptides (AMP) against several microorganism and tumor cells has been proposed their association with the immune system. However, just a few reports have shown this relationship. In this study, mice were treated with gomesin, a ␤-hairpin AMP that exhibit high cytotoxicity against bacterial and tumor cells. Different effects in the immune system were observed, such as, decrease of CD3 + in T lymphocytes (Control: 17.7 ± 1.4%; Gomesin: 7.67 ± 1.2%) and in hematopoietic progenitors and increase of hematopoietic stem cell (Control: 0.046 ± 0.004%; Gomesin: 0.067 ± 0.003%), B220 + B lymphocytes (Control: 38.63 ± 1.5%; Gomesin: 47.83 ± 0.48%), and Mac-1 + F4/80 + macrophages (Control: 11.76 ± 3.4%; Gomesin: 27.13 ± 4.0%). Additionally, macrophage increase was accompanied by an increase of macrophage phagocytosis (Control 20.85 ± 1.53; Gomesin 31.32 ± 1 Geometric mean), interleukin 6 (Control: 47.24 ± 1.9 ng/mL; Gomesin: 138.68 ± 33.68 ng/mL) and monocyte chemoattractant protein-1 (Control: 0.872 ± 0.093 ng/mL; Gomesin: 1.83 ± 0.067 ng/mL). Thus, this report showed immunomodulatory activity of gomesin in the immune system of mice.
Introduction
Antimicrobial peptides (AMPs) are present in nearly all organisms displaying diverse tridimensional structures. Due to the presence of AMPs in the most of species and its ability to kill several microorganism, AMPs have been associated to the immune system. AMPs with immunomodulatory activity are called of host defense peptides, these peptides are typically expressed in macrophages, neutrophils, mast cells, stromal bone marrow and mucosal epithelial cells [1] [2] [3] [4] [5] . The host defense peptides from cathelicidins and defensins families are the best characterized [3, 5, 6] .
Among the known AMPs most of them are cationic, amphipathic and with molecular weights of less than 10 kDa [7] . Their mode of action has not been completely elucidated, however, several models of interaction with bacterial and eukaryotic plasma membrane have been proposed [8] [9] [10] . Despite the classical models of interac-tion of AMPs with bacterial membranes, such as barrel-stave model, toroidal pore model and carpet model [11] , more complex actions seems to occurs in mammals cells. For instance, internalization into the cells seems to be particularly important in their cytotoxic effect [12] [13] [14] . Several reports have shown the internalization of AMPs and intracellular targets such organelles and DNA, but is unknown in detail how AMPs can affect internal cellular targets [11, 13] . Cytotoxic effects in mammals cells occurs by several mechanism such as membrane permeabilization [12] , caspase-dependent apoptosis [15] , or autophagy [16] . When associated with the immune system AMPs have showed chemotactic activity against macrophages, neutrophils [17] , dendritic cells [18] , and degranulation of mast [19] .
Among AMPs, we point out gomesin (Gm) that is a well-studied ␤-hairpin AMP containing 18 amino acid residues, including 4 cysteines engaged in two internal disulfide bridges, Cys 2−15 and Cys 6−11 . It contains two posttranslational modifications, a pyroglutamic acid (Z) as the N-terminus and an amidated arginine residue as the C-terminus. The entire sequence is ZCRRLCYKQRCVTYCRGR-NH 2 . Gm was isolated from the hemocytes of the Brazilian spider Acanthoscurria gomesiana. Gm exhibits high cytotoxicity against bacteria, fungi, yeast, and parasites [20] [21] [22] [23] [24] . It is commonly assumed that the main antimicrobial mechanism of Gm, and other AMPs involves membrane permeabilization and destabilization. The main activity described of Gm in mammals cells is its cytotoxic activity against B16 melanoma tumor cells [25] , neuroblastoma SH-SY5Y, pheochromocytoma PC12 cells [26] , leukemic lineages [8] , and cell hamster Chinese cells [13] . Intracellular mechanism triggered by Gm to induce cell death was related to endoplasmic reticulum disturbance, cytosolic Ca 2+ increase, followed by an accumulation of Ca 2+ in organelles, which induces loss of mitochondria potential leading to collapse of mitochondria, which culminates with the disruption of cellular membrane [13, 26] . The structural characteristics of Gm are associated to cytotoxic activity and has been related with its disulfide bridges that are responsible to its ␤-hairpin conformation, degradation resistance, and interaction with cell membrane [27] [28] [29] .
In this paper we decide to expand our acknowledge about the Gm molecule and evaluate its effect in the immune system in a murine model.
Experimental procedures

Peptide synthesis
Gm was synthesized manually by the solid-phase method on a 4-methylbenzhydrylamine-resin (MBHAR) (0.8 mM/g) using the t-Boc strategy [27] . Full deprotection and cleavage of the peptide from the resin were carried out using anhydrous hydrogen fluoride (HF) treatment with anisole and dimethyl sulfide (DMS) as scavengers at 0 • C for 1.5 h. Formation of disulfide bridges was achieved immediately after the HF cleavage and extraction of the crude peptide. The resulting peptide solution was kept at pH 6.8-7.0 and 5 • C for 72 h. Cyclization reactions were monitored by reverse-phase liquid chromatography coupled to an electrospray ionization mass spectrometer (LC/ESI-MS). Lyophilized crude peptides were purified by preparative RP-HPLC on a Vydac C 18 column (25 × 250 mm, 300 Å pore size, and 15 m particle size) in two steps. The first was performed by using triethylammonium phosphate (TEAP) pH 2.25 as solvent A and 60% acetonitrile (ACN) in A as solvent B. The second step was carried out using 0.1% trifluoroacetic acid (TFA) H 2 O as solvent A and 60% ACN in A as solvent B. Pure peptides were characterized by amino acid analysis and by LC/ESI-MS.
Animals
In this study, 3-month-old male C57BL/6 mice were used. Animals were supplied by INFAR/UNIFESP Animal Facility. All experiments were approved by the Animal Care Ethics Committee of Universidade Federal de São Paulo (0225/10). Mice were euthanized by cerebral concussion and the bone marrow was extracted from femoral cavity.
In vivo assays
Experimental animals were daily intraperitoneally administered 100 L of sterile saline, pH 7.4 of Gm at 1 or 3 mg/kg body weight for 3 days; the control animals were simultaneously administered equal sterile saline volumes.
Bone marrow immunophenotyping
Hematopoietic populations were identified by flow cytometry as described previously [30, 31] . HSC cells were identified using a lineage marker cocktail (Lin: PE-conjugated B220, CD3, Ter-119, CD11b and Gr-1). Additionally, several antibodies (FLK-2-PE, IL-7R-PE, CD90-FITC, Sca-1-Cy7/PE and c-Kit-APC) were used to recognize a subset rich in HSCs: Lin − FLK-2 − Sca-1 + c-Kit + Thy1.1 + . Moreover, common myeloid progenitors (CMP): Lin − IL-7R − c-Kit + Sca-1 − CD34 + Fc R low ); granulocyte/monocyte progenitor (GMP): Lin − IL-7R − c-Kit + Sca-1 − CD34 + Fc R high ; megakaryocyte-erythroid progenitor (MEP): Lin − IL-7R − c-Kit + Sca-1 − CD34 − Fc R low populations were identified using IL-7R-PE, Sca-1-PE, c-Kit-Cy7/PE, CD34-FITC and FC R-APC antibodies. Mature populations were identified as myeloid cells: Mac-1 + Gr-1 + F4/80 − ; monocyte/macrophage: Mac-1 + F4/80 + Gr-1 − ; T cell: CD3 + B220 − Gr-1 − ; B cells: B220 + CD3 − Gr-1 − . All antibodies were purchased from Becton Dickinson (Franklin Lakes, NJ, USA). We captured 300.000,00 events to evaluate hematopoietic progenitor's populations and 30.000,00 to evaluate mature populations. Flow cytometry was performed on a BD Accuri C6 cytometer (Becton Dickinson, USA). For data analyzes FlowJo v10 software (Tree StarInc., Ashand, OR) was used.
Colony forming unity (CFU) assay
CFU assays were performed by plating 2 × 10 4 murine bone marrow cells in methylcellulose-based medium with recombinant cytokines and EPO (Methocult M3434; StemCell Technologies, USA) in 35-mm diameter dishes. The cells were cultured in a fully humidified air incubator under 5% CO 2 at 37 • C for 7 or 14 days for murine and human cells, respectively. At the end of the incubation period, colonies of more than 50 cells were counted using a dark field microscope [30, 31] .
Macrophage phagocytosis assay
The phagocytic capacity of J774 macrophages was determined using heat-killed Escherichia coli labeled with the pH-dependent dye pHRODO (Life Technologies, Carlsbad, CA). After stimulation with Gm, about 2 × 10 8 labeled E. coli were added to 2 × 10 5 J774 cell line cultures and analyzed using flow cytometry (excitation: 488 nm; emission: 585/26 nm for pHRODO Red BioParticles conjugates), according to manufacturer's instructions. Flow cytometry was performed on a BD Accuri C6 cytometer (Becton Dickinson, USA). For data analyzes FlowJo v10 software (Tree StarInc., Ashand, OR) was used.
Quantification of Cytokines
The cytokines present in mouse plasma were measured using BD TM Cytometric Bead Array (CBA) Mouse Inflammation Kit, accordingly with manufacturer instructions. Briefly, blood was extracted by cardiac puncture, and the plasma obtained by centrifugation. Next, the anti-cytokines Beads were added to 300 L of plasma, washed with PBS and labeled. A standard curve was obtained using cytokines standards. Flow cytometry was performed on an Accuri C6 cytometer (Becton Dickinson, USA). For data analyzes FlowJo v10 software (Tree StarInc., Ashand, OR) was used.
Were quantified: interleukin 6 (IL-6), interleukin 10, monocyte chemoattractant protein 1 (MCP-1), interferon ␥, Tumor necrosis factor, and interleukin 12.
Statistical analysis
All data represent at least three independent experiments and were expressed as mean ± standard error of the mean (SEM). Statistical analyzes were performed using Student's t-test for comparison between two groups, and analysis of variance (ANOVA) and Dunnett's post hoc test for multiple comparisons among groups. A probability value of P < 0.05 was considered significant. 
Results
In order to verify the ability of Gm to modulate the immune system, mice were intraperitoneallly treated with Gm for three days using two different doses. Several hematopoietic populations were altered in bone marrow, spleen or peripheral blood. Populations no affected are showed in Supplementary information S1 (P > 0.05). The dose of 3 mg/kg produced several changes in hematopoietic populations. Increase of hematopoietic stem cells (Control: 0.046 ± 0.004%; Gomesin: 0.067 ± 0.003%) (Fig. 1A) and a significant decrease of common myeloid progenitor (Control: 0.48 ± 0.5%; Gomesin: 0.25 ± 0.01%; P < 0.05) (Fig. 1B) were observed by treatment with Gm, although other hematopoietic progenitors were not affected. The decrease of myeloid progenitors population was confirmed by methylcellulose, where a decrease in granulocyte/monocyte and erythrocyte colonies was observed (Control: 68 ± 2.31%; Gomesin 10 −6 M: 46 ± 2.3%; P < 0.05) (Fig. 1C) using concentration that did not produced cell death [8, 13, 25, 26, 29] . Additionally, an evaluation of hematopoietic cells of peripheral blood, spleen and bone marrow also showed alterations in some hematopoietic populations caused by Gm. Gm also induced a decrease of T cells (Control: 17.7 ± 1.4%; Gomesin: 7.67 ± 1.2%; P < 0.05) (Fig. 1D) and an increase of spleen B lymphocytes (Control: 38.63 ± 1.5%; Gomesin: 47.83 ± 0.48%; P < 0.05) (Fig. 1E) were also observed. Moreover, a consistent increase of macrophages (Mac-1 + F4/80 + ) in blood (Control: 11.76 ± 3.4%; Gomesin: 27.13 ± 4.0%; P < 0.05) (Fig. 1F ) and bone marrow (Control: 15.85 ± 2.23%; Gomesin: 32.2 ± 2.2%; P < 0.05) (Fig. 1G) were also observed; this fact was further investigated. Then, we also tested the ability of the Gm in the activation of macrophages measuring phagocytation induction. Gm was able to increase phagocytation ability of macrophages in cultures (Control 20.85 ± 1.53; Gomesin 31.32 ± 1 Geometric mean) (Fig. 1H) , and induce the increase of IL-6 (Control: 47.24 ± 1.9 ng/mL; Gomesin: 138.68 ± 33.68 ng/mL) (Fig. 1I) , and MCP-1 associated to inflammatory process (Control: 0.872 ± 0.093 ng/mL; Gomesin: 1.83 ± 0.067 ng/mL) (Fig. 1J) . IL-10, interferon ␥, tumor necrosis factor, and interleukin 12 were not affected by the treatment with Gm.
Discussion
Immune defenses include evolutionarily ancient systems such as AMPs that are involving to immune system of several kingdoms. Herein, we evaluated some immunomodulatory changes caused by the Gm ␤-hairpin AMP in a mouse model. Gm was able to induce changes in the percentages of lympho-hematopoietic cells in different compartments, such as bone marrow, spleen, and blood. Gm treatments produced an increase of HSC, the most primitive hematopoietic population source of all hematopoietic cells. The increase of HSC induced by Gm was accompanied by a reduc-tion of hematopoietic progenitors, as observed by flow cytometry, and methylcellulose, but with an increase of progenitors in bone marrow, and an increase of peripheral monocytes/macrophages. Turnover of HSC is slow [32, 33] , but myeloid progenitors exhibited a higher rate of proliferation and differentiation, it is usually assumed that myeloid differentiation takes approximately 48-72 h in mice [33] . This increase of monocytes/macrophage could be explained by the differentiation of progenitors that reduced its number in bone marrow probably to compensate the immune system. Few reports have showed direct ability of AMPs to regulate primitive hematopoietic cells. Bone marrow stroma-released LL-37, a host-defense peptide member of the cathelicidin family, enhanced bone marrow recovery by its chemoattractant propriety [34] . Direct modulation of neutrophils was also observed by the AMP KSLW (KKVVFWVKFK-NH 2 ), which produced chemotactic for neutrophils, F-actin polymerization, and inhibited oxygen radical production in PMA-and LPS-stimulated neutrophils [35] .
In cases of infections, an increase of myeloid progenitors in bone marrow, neutrophils, and monocytes/macrophage in peripheral blood occurs [36, 37] . These changes can be related to release of proinflammatory cytokines produced by several cells types. Cytokines orchestring the inflammatory process, with recruitment of neutrophils, monocytes and lymphocytes, and some studies reported the direct response of HSC to pro-inflammatory cytokines [36, 37] . Some AMPs have been able to modulate secretion of cytokines in the immune response to bacterial infection in mice. The increase of the production of pro-inflammatory cytokines is more usual, as observed with an analogue of hymenochirin-1B, an ␣-helical host-defense peptide, which stimulates the production of the antiinflammatory cytokines IL-4, and IL-10 [38] ; or the host-defense peptides obtained from frog frenatin 2.1S and 2.2S that increased the production of pro-inflammatory cytokines IL-1␤, and IL-23 by macrophages [39] . On the other hand, some AMPs stimulate modulation of pro-and anti-inflammatory cytokines simultaneously. For example, epinecidin-1, a AMP that mediates secretion of immunoglobulin G and IL-10 in the immune response to bacterial infection [40] ; and pseudhymenochirins, the host-defense peptides, first isolated from skin secretions of a frog, which reduced the production of anti-inflammatory cytokines IL-10, and IL-6; but enhance the production of the pro-inflammatory cytokine IL-23 of macrophages [41] . Gm also induced an increase of IL-6 and MCP-1 production and in the phagocytation, but interestingly, did not affect the anti-inflammatory cytokines.
Increase of monocytes/macrophage by treatment with Gm in bone marrow and blood compartments, was also accompanied by an increase of phagocytes activity, demonstrating the capability of Gm to modulate macrophage activation. Those found was not was observed in the hemocytes of the spider Acanthoscurria gomesiana, whereas the main role seem to be associated to coagulation and AMPs secretion [42] .
Several cells and activated macrophages cause cytokines release, such as tumor necrosis factor alpha, interferon ␤, interleukins 1, 6, 10, 12, and 18 [43] . Treatment with Gm in vivo model promoted an increase of IL-6 and MCP-1, a chemokine that attract monocytes, corroborating to the found of the modulatory effect of Gm. Modulation of lymphoid cells was also observed, but these alterations were not investigated and deserve further investigation to understand the implications of Gm in lymphoid cells.
Mode of actions of Gm and others AMPs remains unclear. Binding to cellular membrane receptor it is not possible, since the D-Gm compound also presents similar effects than L-Gm [8] . Due to its strong interaction with membrane phospholipids some molecules could be release from plasma membrane and cause the observed effect [44] .
Some other reports have shown that after Gm interaction to the cell membrane, internalization by direct translocation or endocytosis mechanisms could happen [45] [46] [47] . It is probably that the peptide internalization, by the classic AMP mechanism of action or endocytosis-mediated mechanisms (macropinocytosis, clathrindependent, caveolin-dependent or clathrin/caveolin independent) may occur simultaneously. The difficulty to evaluate how AMPs can trigger intracellular mechanism prevents the fully understanding of regulation of immune system.
Conclusion
This report shows that Gm induced changes in the percentages of different hematopoiesis cells, increasing HSC, decreasing myeloid progenitors, increasing monocytes/macrophages phagocytation, and produced an increase in the production of IL-6 and MCP-1 in mice.
